Skip to main content

Table 2 The concentrations of Δ9-THC and CBD derived from each cannabis cultivar extract

From: A pharmacological characterization of Cannabis sativa chemovar extracts

Cultivar Sample

Cannabinoid Concentration (mg/ml)

  

Δ9-THC

CBD

CBC

CBG

CBDV

CBDA

CBN

THCV

THCA

CBDVA

CBGA

Max dose Δ9-THC administered (mg/kg)

Max dose CBD administered (mg/kg)

CTL-H01.H3c

7.54

0.02

0.17

0.20

a

0.07

0.06

0.69

3

0.01

CTL-H01.H2

3.23

a

0.06

0.10

a

a

0.06

0.13

a

a

6

a

CTL-P01.H1

1.98

4.52

0.31

0.02

0.03

0.09

a

a

a

a

b

6

13.7

CTL-G01.H8

0.50

6.52

1.39

0.04

0.07

0.93

0.06

a

a

a

b

3

39.1

CTL-G03.H2

0.72

5.49

0.72

a

0.01

0.77

a

b

a

a

b

3

22.9

CTL-X02.H1

0.45

2.91

0.37

0.107

0.09

1.31

0.041

0.05

0.77

2

12.9

  1. (−) indicates cannabinoid was not determined in the preparation
  2. abLOQ Below level of quantification for the cultivar assay range (0.977–500 ng Δ9-THC/mL). Refers to the limit at which the difference between two distinct values can be distinguished using the assay
  3. bbLOD Below level of detection for cultivar assay range for all cultivars. The lowest quantity of the extract component distinguished from the absence of that substance (i.e., blank value) with a confidence level of 99%
  4. cIndicates sample was re-tested
  5. CBDVA Cannabidivarin acid, CBDV Cannabidivarin, CBDA Cannabidiolic Acid, CBG Cannabigerol, CBD Cannabidiol, THCV Δ9-Tetrahydrocannabivarin, CBN Cannabinol, Δ9-THC Δ9-tetrahydrocannabinol (Δ9-THC), CBC Cannabichomene, THCA Δ9-Tetrahydrocannabinolic acid